MariMed COO Timothy Shaw converts award to 9,981 shares
The chief operating officer's RSU vesting included 3,459 shares withheld for tax obligations, while remaining RSUs under the grant will vest in full on April 2, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MariMed Inc. (MRMD) Chief Operating Officer Timothy Shaw converted 9,981 RSUs into 9,981 common shares on October 2, 2026. The issuer withheld 3,459 shares for tax withholding obligations at $0.0696 per share. The transaction reports 9,982 RSUs following conversion; the remaining RSUs under the grant will vest in full on April 2, 2027. Separately, the Shaw Family Trust held 2,000,000 common shares; Shaw's spouse is trustee, the shares benefit his children, and Shaw disclaims beneficial ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (RSU) F1, F4 | 9,981 | $0.00 | $0.00 |
| Exercise | Common stock F1 | 9,981 | $0.00 | $0.00 |
| Tax Withholding | Common stock F2 | 3,459 | $0.0696 | $240.75 |
| holding | Common stock F3 | -- | -- | -- |
Footnotes (4)
- F1. RSUs convert to shares of common stock on a one-for-one basis.
- F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
- F3. The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. The RSUs were granted on April 2, 2024; the remaining RSUs under this grant will vest in full on April 2, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Key Figures
Key Terms
RSUs financial
tax withholding obligations financial
irrevocable trust regulatory
beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When do the remaining MRMD RSUs vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.